| Datum | Zeit | Quelle | Überschrift | Symbol | Firma |
| 13/09/2017 | 15h40 | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (defa14a) | AMEX:MSTX | Mast Therapeutics, Inc. (delisted) |
| 13/09/2017 | 15h34 | Edgar (US Regulatory) | Proxy Statement (definitive) (def 14a) | AMEX:MSTX | Mast Therapeutics, Inc. (delisted) |
| 07/09/2017 | 14h51 | Edgar (US Regulatory) | Current Report Filing (8-k) | AMEX:MSTX | Mast Therapeutics, Inc. (delisted) |
| 09/08/2017 | 14h48 | Edgar (US Regulatory) | Quarterly Report (10-q) | AMEX:MSTX | Mast Therapeutics, Inc. (delisted) |
| 09/08/2017 | 14h21 | Edgar (US Regulatory) | Current Report Filing (8-k) | AMEX:MSTX | Mast Therapeutics, Inc. (delisted) |
| 24/07/2017 | 23h21 | Edgar (US Regulatory) | Current Report Filing (8-k) | AMEX:MSTX | Mast Therapeutics, Inc. (delisted) |
| 29/06/2017 | 23h00 | Edgar (US Regulatory) | Statement of Ownership (sc 13g) | AMEX:MSTX | Mast Therapeutics, Inc. (delisted) |
| 29/06/2017 | 22h52 | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | AMEX:MSTX | Mast Therapeutics, Inc. (delisted) |
| 12/06/2017 | 22h21 | Edgar (US Regulatory) | Statement of Ownership (sc 13g) | AMEX:MSTX | Mast Therapeutics, Inc. (delisted) |
| 09/06/2017 | 16h39 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | AMEX:MSTX | Mast Therapeutics, Inc. (delisted) |
| 09/06/2017 | 16h37 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | AMEX:MSTX | Mast Therapeutics, Inc. (delisted) |
| 09/06/2017 | 16h35 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | AMEX:MSTX | Mast Therapeutics, Inc. (delisted) |
| 09/06/2017 | 16h35 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | AMEX:MSTX | Mast Therapeutics, Inc. (delisted) |
| 09/06/2017 | 16h32 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | AMEX:MSTX | Mast Therapeutics, Inc. (delisted) |
| 09/06/2017 | 16h31 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | AMEX:MSTX | Mast Therapeutics, Inc. (delisted) |
| 06/06/2017 | 12h04 | Edgar (US Regulatory) | Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) | AMEX:MSTX | Mast Therapeutics, Inc. (delisted) |
| 02/06/2017 | 23h08 | Edgar (US Regulatory) | Current Report Filing (8-k) | AMEX:MSTX | Mast Therapeutics, Inc. (delisted) |
| 01/06/2017 | 22h15 | Edgar (US Regulatory) | Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) | AMEX:MSTX | Mast Therapeutics, Inc. (delisted) |
| 01/06/2017 | 22h11 | Edgar (US Regulatory) | Current Report Filing (8-k) | AMEX:MSTX | Mast Therapeutics, Inc. (delisted) |
| 30/05/2017 | 17h51 | Edgar (US Regulatory) | Current Report Filing (8-k) | AMEX:MSTX | Mast Therapeutics, Inc. (delisted) |
| 27/05/2017 | 00h55 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | AMEX:MSTX | Mast Therapeutics, Inc. (delisted) |
| 27/05/2017 | 00h47 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | AMEX:MSTX | Mast Therapeutics, Inc. (delisted) |
| 11/05/2017 | 22h31 | Edgar (US Regulatory) | Securities Registration: Employee Benefit Plan (s-8) | AMEX:MSTX | Mast Therapeutics, Inc. (delisted) |
| 10/05/2017 | 12h06 | Edgar (US Regulatory) | Current Report Filing (8-k) | AMEX:MSTX | Mast Therapeutics, Inc. (delisted) |
| 09/05/2017 | 22h49 | Edgar (US Regulatory) | Quarterly Report (10-q) | AMEX:MSTX | Mast Therapeutics, Inc. (delisted) |
| 08/05/2017 | 17h28 | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | AMEX:MSTX | Mast Therapeutics, Inc. (delisted) |
| 03/05/2017 | 18h53 | Edgar (US Regulatory) | Current Report Filing (8-k) | AMEX:MSTX | Mast Therapeutics, Inc. (delisted) |
| 01/05/2017 | 15h08 | Edgar (US Regulatory) | Current Report Filing (8-k) | AMEX:MSTX | Mast Therapeutics, Inc. (delisted) |
| 01/05/2017 | 15h02 | Edgar (US Regulatory) | Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) | AMEX:MSTX | Mast Therapeutics, Inc. (delisted) |
| 28/04/2017 | 23h31 | Edgar (US Regulatory) | Current Report Filing (8-k) | AMEX:MSTX | Mast Therapeutics, Inc. (delisted) |